This report summarizes paired-end fungal genome analysis for Candida-focused surveillance, combining read QC, Kraken2/Bracken species typing, MEGAHIT assembly, QUAST-only assembly contiguity assessment, and genomic antifungal-resistance screening.
Run generated: 2026-05-31 15:17:50 UTCRun stamp: 20260531_151750_UTCCustom Candida Kraken2/Bracken DBMEGAHIT assemblyThe primary detected fungal species group was Candidozyma auris. The sample-level cards below provide a compact interpretation of species assignment, QUAST assembly-contiguity metrics, phylogeny status, and genomic AMR screening status.
This integrated table combines species confidence, QUAST assembly-contiguity metrics, AMR marker status, phylogeny eligibility, and optional metadata into a practical surveillance-readiness view.
| Sample | Collection date | site | species | Species confidence | Assembly QC | QUAST contiguity QC | AMR screen | Phylogeny | Surveillance status | Reason / note |
|---|---|---|---|---|---|---|---|---|---|---|
| SRR19214212 | 2021-04 | Lagos | Candidozyma auris | High | Review | Review | 1 marker(s) | Included / eligible | Review | QUAST assembly QC; AMR marker detected |
| SRR19214213 | 2021-03 | Lagos | Candidozyma auris | High | Pass | Pass | No curated marker detected | Included / eligible | Ready for surveillance interpretation | No major automated warning flags using species typing, QUAST assembly QC, AMR screening, and phylogeny status |
| SRR19214214 | 2021-02 | Lagos | Candidozyma auris | High | Pass | Pass | No curated marker detected | Included / eligible | Ready for surveillance interpretation | No major automated warning flags using species typing, QUAST assembly QC, AMR screening, and phylogeny status |
| SRR19214215 | 2021-02 | Lagos | Candidozyma auris | High | Pass | Pass | 1 marker(s) | Included / eligible | Review | AMR marker detected |
| Sample | country | site | collection_date | specimen_type | patient_group | ward_or_facility | sequencing_platform |
|---|---|---|---|---|---|---|---|
| SRR19214215 | Nigeria | Lagos | 2021-02 | blood | human | Lagos | ILLUMINA; Illumina MiSeq |
| SRR19214212 | Nigeria | Lagos | 2021-04 | blood | human | Lagos | ILLUMINA; Illumina MiSeq |
| SRR19214213 | Nigeria | Lagos | 2021-03 | blood | human | Lagos | ILLUMINA; Illumina MiSeq |
| SRR19214214 | Nigeria | Lagos | 2021-02 | blood | human | Lagos | ILLUMINA; Illumina MiSeq |
1 AMR hit(s) Species confidence: High Phylogeny: Included / eligible
No curated genomic AMR marker detected — not susceptible Species confidence: High Phylogeny: Included / eligible
No curated genomic AMR marker detected — not susceptible Species confidence: High Phylogeny: Included / eligible
1 AMR hit(s) Species confidence: High Phylogeny: Included / eligible
Top species calls are derived from the custom Candida-focused Kraken2/Bracken database bundled in the species-typing Docker image.
| Sample | Top species | Reads (%) | clade_reads | taxon_reads | taxid | evidence |
|---|---|---|---|---|---|---|
| SRR19214212 | Candidozyma auris | 98.09% | 2,142,657 | 2,142,657 | 498019 | Bracken species-level abundance |
| SRR19214213 | Candidozyma auris | 99.52% | 4,139,459 | 4,139,459 | 498019 | Bracken species-level abundance |
| SRR19214214 | Candidozyma auris | 99.23% | 3,195,831 | 3,195,831 | 498019 | Bracken species-level abundance |
| SRR19214215 | Candidozyma auris | 98.41% | 2,451,911 | 2,451,911 | 498019 | Bracken species-level abundance |
| Sample | contigs | Total bp | N50 | Largest contig |
|---|---|---|---|---|
| SRR19214212 | 8,519 | 31,436,259 | 8,028 | 405,307 |
| SRR19214213 | 286 | 12,330,599 | 84,821 | 305,683 |
| SRR19214214 | 295 | 12,315,236 | 79,213 | 269,740 |
| SRR19214215 | 300 | 12,358,560 | 83,466 | 474,419 |
QUAST values are parsed from the native per-sample report.tsv format and transposed into one row per sample. This default surveillance mode reports QUAST assembly contiguity metrics such as contig count, total length, N50, largest contig, and GC percentage. It is very fast. BUSCO and Compleasm tasks are available as optional modules, but they are disabled by default in the recommended JSON and are not required for this QUAST-based assembly assessment.
| Sample | # contigs | Largest contig | Total length | GC (%) | N50 |
|---|---|---|---|---|---|
| SRR19214212 | 8,519 | 405,307 | 31,436,259 | 38.76 | 8,028 |
| SRR19214213 | 286 | 305,683 | 12,330,599 | 45.09 | 84,821 |
| SRR19214214 | 295 | 269,740 | 12,315,236 | 45.09 | 79,213 |
| SRR19214215 | 300 | 474,419 | 12,358,560 | 45.03 | 83,466 |
This section reports mutation/gene-level evidence emitted by the configured fungal AMR container. A “No marker detected” result is not a susceptible call. Fluconazole resistance can be caused by ERG11 alterations, TAC1/UPC2/MRR1/PDR1-mediated efflux, aneuploidy/LOH, copy-number changes, species-specific mechanisms, or markers absent from the current AMR database.
| Sample | species | drug_class | drug | Gene / status | mutation | effect | evidence_level | interpretation |
|---|---|---|---|---|---|---|---|---|
| SRR19214212 | Candidozyma auris | azole/echinocandin/polyene/flucytosine | fluconazole/other azoles/echinocandins/amphotericin_B/flucytosine | Cyp51 | Y132F | FungAMR MUTATION | FungAMR curated marker detected by ChroQueTas | Curated ChroQueTas/FungAMR marker detected: Cyp51 Y132F (FungAMR MUTATION). Drug evidence from ChroQueTas: 5-fluorocytosine(NA/-8),Amphotericin_B(8/-8),Anidulafungin(NA/-8),Caspofungin(8/-8),Fluconazole(2/-8),Itraconazole(8/-8),Micafungin(NA/-8),Posaconazole(8/-8),Voriconazole(2/-8). Source: amr_out/SRR19214212.ChroQueTas/SRR19214212.contigs.ChroQueTaS.Cyp51.1.tsv:132 |
| SRR19214213 | Candidozyma auris | azole/other | fluconazole/other | No marker — not susceptible | NA | NA | scanner_detected_candidate_marker | The AMR scanner produced text consistent with a possible curated resistance marker, but rc151 could not parse an exact ChroQueTas marker row. Review fungal_amr.raw.tsv and fungal_amr.log for the exact record: amr_out/SRR19214213.ChroQueTas.AMR_summary.tsv No AMR mutations found in SRR19214213.contigs |
| SRR19214214 | Candidozyma auris | azole/other | fluconazole/other | No marker — not susceptible | NA | NA | scanner_detected_candidate_marker | The AMR scanner produced text consistent with a possible curated resistance marker, but rc151 could not parse an exact ChroQueTas marker row. Review fungal_amr.raw.tsv and fungal_amr.log for the exact record: amr_out/SRR19214214.ChroQueTas.AMR_summary.tsv No AMR mutations found in SRR19214214.contigs |
| SRR19214215 | Candidozyma auris | azole/echinocandin/polyene/flucytosine | fluconazole/other azoles/echinocandins/amphotericin_B/flucytosine | Cyp51 | Y132F | FungAMR MUTATION | FungAMR curated marker detected by ChroQueTas | Curated ChroQueTas/FungAMR marker detected: Cyp51 Y132F (FungAMR MUTATION). Drug evidence from ChroQueTas: 5-fluorocytosine(NA/-8),Amphotericin_B(8/-8),Anidulafungin(NA/-8),Caspofungin(8/-8),Fluconazole(2/-8),Itraconazole(8/-8),Micafungin(NA/-8),Posaconazole(8/-8),Voriconazole(2/-8). Source: amr_out/SRR19214215.ChroQueTas/SRR19214215.contigs.ChroQueTaS.Cyp51.1.tsv:132 |
When enabled, rMAP-Candida builds phylogenies separately for each species with sufficient samples and a matching reference. Mixed-species phylogenies are intentionally avoided. Outputs include species-group summaries, core-SNP alignments, and IQ-TREE Newick trees.
| Species | Status | Samples | Variant-calling branch | Ploidy model | Core variable sites | Notes |
|---|---|---|---|---|---|---|
| Candidozyma auris | PASS | 4 | snippy_core_rc170_tb_style | NA | 199274 | rc170 used the rMAP-TB-style Snippy -> snippy-core branch. Species grouping was based on Kraken2/Bracken top-species calls; mixed-species trees are intentionally avoided. Recombination is not explicitly filtered. |
| species | Sample | Closest sample | SNP distance | Conservative cluster flag |
|---|---|---|---|---|
| Candidozyma auris | SRR19214212 | SRR19214215 | 225 | Distinct / review with metadata |
| Candidozyma auris | SRR19214213 | SRR19214214 | 235 | Distinct / review with metadata |
| Candidozyma auris | SRR19214214 | SRR19214213 | 235 | Distinct / review with metadata |
| Candidozyma auris | SRR19214215 | SRR19214212 | 225 | Distinct / review with metadata |
| species | Sample A | Sample B | SNP distance | Compared core-SNP sites |
|---|---|---|---|---|
| Candidozyma auris | SRR19214212 | SRR19214213 | 166198 | 199274 |
| Candidozyma auris | SRR19214212 | SRR19214214 | 166208 | 199274 |
| Candidozyma auris | SRR19214212 | SRR19214215 | 225 | 199274 |
| Candidozyma auris | SRR19214213 | SRR19214214 | 235 | 199274 |
| Candidozyma auris | SRR19214213 | SRR19214215 | 166227 | 199274 |
| Candidozyma auris | SRR19214214 | SRR19214215 | 166210 | 199274 |
The workflow emits downloadable tabular outputs in addition to this integrated HTML report.